Trending Now
Sanofi SA (NASDAQ:SNY) and GlaxoSmithKline plc (NYSE:GSK) Announce the First-in-Human Trial...
Threats from the Covid-19 pandemic are large enough. This calls for multiple types of approaches in the development of a potential vaccine. A few...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
iBio Inc. (NYSEAMERICAN:IBIO) Initiates Studies For Second Coronavirus Vaccine Platform
iBio Inc. (NYSEAMERICAN:IBIO) has announced that it has initiated preclinical immunization trials for its second coronavirus vaccine platform.
iBio commences second COVID-19 vaccine platform trials...
MAKE IT MODERN
LATEST REVIEWS
Porch Group Stock Jumps 70%: Is This Home Insurance Tech Play...
Porch Group (PRCH), the home insurance and software platform, experienced a dramatic surge in its stock price, closing over 70% higher after...
MAKE IT MODERN
PERFORMANCE TRAINING
Wall Street (S&P 500 Index) is all but confused
It has been a mixed day today for the SPY trade. In many ways it's been trading like a Monday though it's...
Social Media Influencer Stocks are Changing the Game (FB, ENGMF, TONJ, SNAP)
The social media influencer space is the future of marketing and branding, a fact made very clear by the recent story of Kylie Cosmetics,...
Titan Pharmaceuticals (TTNP) Announces Strategic Merger with KE Sdn. Bhd.
In a significant move poised to reshape its business landscape, Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), based in South San Francisco, CA, announced...
Sangamo Therapeutics Inc (NASDAQ:SGMO) Inks A Collaboration Agreement With Novartis AG (NYSE:NVS) To Develop...
Sangamo Therapeutics Inc (NASDAQ:SGMO) entered an international licensing collaboration accord with Novartis AG (NYSE:NVS) to commercialize/ develop gene regulation therapies (GRT).
GRT targets ASD
Sangamo will...
Titan Pharmaceuticals Inc.’s (NASDAQ:TTNP) Partner Enters Exclusive Commercialization agreement For Probuphine In EU with...
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) has announced that it's Molteni Farmaceutici partner has signed an exclusive commercialization agreement with Accord Healthcare for Sixmo®, which is...
MAKE IT MODERN
